Coronation Fund Managers Ltd. Haleon PLC Transaction History

Coronation Fund Managers Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$8.01 - $8.64 $25,968 - $28,010	-3,242 Reduced 14.84%	18,600 $153,000
Q1 2024 May 03, 2024	SELL	$8.02 - $8.67 $1.71 Million - $1.85 Million	-213,122 Reduced 90.7%	21,842 $185,000
Q4 2023 Feb 09, 2024	BUY	$7.78 - $8.62 $99,685 - $110,448	12,813 Added 5.77%	234,964 $1.93 Million
Q3 2023 Oct 18, 2023	BUY	$7.85 - $8.94 $123,025 - $140,107	15,672 Added 7.59%	222,151 $1.85 Million
Q2 2023 Jul 27, 2023	BUY	$8.04 - $9.0 $20,003 - $22,392	2,488 Added 1.22%	206,479 $1.73 Million
Q1 2023 May 05, 2023	SELL	$7.57 - $8.37 $121,581 - $134,430	-16,061 Reduced 7.3%	203,991 $1.66 Million
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.06 $1.31 Million - $1.77 Million	220,052 New	220,052 $1.76 Million

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Coronation Fund Managers Ltd., based on Form 13F filings with the SEC.

Stay updated on Coronation Fund Managers Ltd. with notifications on news.